Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa

NCT03068780 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidermolysis Bullosa

Interventions

DRUG: Oleogel-S10
DRUG: Control gel

Sponsor

Amryt Research Limited